Association between Aquaporin 7 Expression and Myocardial Protection with Nicorandil or Del Nido Cardioplegia: An Experimental Study
DOI:
https://doi.org/10.59958/hsf.7129Keywords:
aquaporin 7, cardioprotection, nicorandil, del Nido cardioplegia, murine heartAbstract
Background: Aquaporin 7 (AQP7), a member the aquaglyceroporin subgroup of the AQP family, is a water channel that controls transport of glycerol and water in heart tissues. It facilitates the uptake of glycerol, a substrate for cardiac energy production, in cardiomyocytes. St. Thomas' Hospital cardioplegic solution No. 2 has cardio-protective effect even in AQP7-deficient hearts. Here, we aimed to determine whether nicorandil or del Nido cardioplegia (DNC) solution can protect AQP7-deficient hearts. Methods: The hearts of male AQP7 knockout (KO) and wild-type (WT) C57/B6N mice (age >15 weeks) were aerobically perfused using the Langendorff technique, and cardiac function was measured as left ventricular diastolic pressure (LVDP) throughout the study. Troponin T was measured as an indicator of myocardial damage after reperfusion for 60 min. We compared WT and KO controls subjected to 25 min of global ischemia as well as WT and KO groups infused with nicorandil (100 µM) for 10 min followed by 25 min of global ischemia. We also compared WT-DNC and KO-DNC hearts administered with DNC for 2 min followed by 23 min of global ischemia (Study 2). Results: The final recovery rates of LVDP were 20.8 ± 7.0%, 28.1 ± 7.6%, 40.0 ± 8.4%, and 38.7 ± 4.7% in the WT control, KO control, WT nicorandil, and KO nicorandil groups, respectively. The LVDP recovered faster in the hearts treated with DNC and reached a significantly higher plateau in the KO than in the WT hearts. Troponin T values were 2144 ± 493 and 1313 ± 717 in the WT and KO groups, respectively (p = 0.041). Conclusion: The Langendorff perfusion model revealed similar myocardial protective effects of nicorandil in AQP7-deficient mice as in WT mice. AQP7 deficiency did not impair the cardioprotective effects of DNC solution.
References
Verkerk AO, Lodder EM, Wilders R. Aquaporin Channels in the Heart-Physiology and Pathophysiology. International Journal of Molecular Sciences. 2019; 20: 2039.
Rojek A, Praetorius J, Frøkiaer J, Nielsen S, Fenton RA. A current view of the mammalian aquaglyceroporins. Annual Review of Physiology. 2008; 70: 301–327.
Egan JR, Butler TL, Au CG, Tan YM, North KN, Winlaw DS. Myocardial water handling and the role of aquaporins. Biochimica et Biophysica Acta. 2006; 1758: 1043–1052.
Rutkovskiy A, Valen G, Vaage J. Cardiac aquaporins. Basic Research in Cardiology. 2013; 108: 393.
Tie L, Wang D, Shi Y, Li X. Aquaporins in Cardiovascular System. Advances in Experimental Medicine and Biology. 2017; 969: 105–113.
Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. Journal of the American College of Cardiology. 1999; 33: 654–660.
IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet (London, England). 2002; 359: 1269–1275.
Tsuchida A, Miura T, Tanno M, Sakamoto J, Miki T, Kuno A, et al. Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C. Journal of the American College of Cardiology. 2002; 40: 1523–1530.
Akao M, Teshima Y, Marbán E. Antiapoptotic effect of nicorandil mediated by mitochondrial atp-sensitive potassium channels in cultured cardiac myocytes. Journal of the American College of Cardiology. 2002; 40: 803–810.
Hoshi A, Yamamoto T, Shimizu K, Sugiura Y, Ugawa Y. Chemical preconditioning-induced reactive astrocytosis contributes to the reduction of post-ischemic edema through aquaporin-4 downregulation. Experimental Neurology. 2011; 227: 89–95.
Shalaby A, Mennander A, Rinne T, Oksala N, Aanismaa R, Narkilahti S, et al. Aquaporin-7 expression during coronary artery bypass grafting with diazoxide. Scandinavian Cardiovascular Journal: SCJ. 2011; 45: 354–359.
Hoshi A, Tsunoda A, Yamamoto T, Tada M, Kakita A, Ugawa Y. Increased neuronal and astroglial aquaporin-1 immunoreactivity in rat striatum by chemical preconditioning with 3-nitropropionic acid. Neuroscience Letters. 2016; 626: 48–53.
Kristensen MLV, Kierulf-Lassen C, Nielsen PM, Krag S, Birn H, Nejsum LN, et al. Remote ischemic perconditioning attenuates ischemia/reperfusion-induced downregulation of AQP2 in rat kidney. Physiological Reports. 2016; 4: e12865.
Hibuse T, Maeda N, Nakatsuji H, Tochino Y, Fujita K, Kihara S, et al. The heart requires glycerol as an energy substrate through aquaporin 7, a glycerol facilitator. Cardiovascular Research. 2009; 83: 34–41.
Marrades MP, Milagro FI, Martínez JA, Moreno-Aliaga MJ. Differential expression of aquaporin 7 in adipose tissue of lean and obese high fat consumers. Biochemical and Biophysical Research Communications. 2006; 339: 785–789.
Maeda N, Funahashi T, Hibuse T, Nagasawa A, Kishida K, Kuriyama H, et al. Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101: 17801–17806.
Fujii M, Ota K, Bessho R. Cardioprotective effect of hyperkalemic cardioplegia in an aquaporin 7-deficient murine heart. General Thoracic and Cardiovascular Surgery. 2020; 68: 578–584.
Fujii M, Bessho R, Akimoto T, Ishii Y. Cardioprotective effect of St. Thomas' Hospital No. 2 solution against age-related changes in aquaporin-7-deficient mice. General Thoracic and Cardiovascular Surgery. 2023. (online ahead of print)
Matte GS, del Nido PJ. History and use of del Nido cardioplegia solution at Boston Children's Hospital. The Journal of Extra-corporeal Technology. 2012; 44: 98–103.
Ad N, Holmes SD, Massimiano PS, Rongione AJ, Fornaresio LM, Fitzgerald D. The use of del Nido cardioplegia in adult cardiac surgery: A prospective randomized trial. The Journal of Thoracic and Cardiovascular Surgery. 2018; 155: 1011–1018.
Mick SL, Robich MP, Houghtaling PL, Gillinov AM, Soltesz EG, Johnston DR, et al. del Nido versus Buckberg cardioplegia in adult isolated valve surgery. The Journal of Thoracic and Cardiovascular Surgery. 2015; 149: 626–634; discussion 634–636.
Zhu F, Zhong X, Zhou Y, Hou Z, Hu H, Liang L, et al. Protective effects of nicorandil against cerebral injury in a swine cardiac arrest model. Experimental and Therapeutic Medicine. 2018; 16: 37–44.
Day RE, Kitchen P, Owen DS, Bland C, Marshall L, Conner AC, et al. Human aquaporins: regulators of transcellular water flow. Biochimica et Biophysica Acta. 2014; 1840: 1492–1506.
Xu WB, Gu YT, Wang YF, Lu XH, Jia LS, Lv G. Bradykinin preconditioning modulates aquaporin-4 expression after spinal cord ischemic injury in rats. Brain Research. 2008; 1246: 11–18.
Gunaydin S, Akbay E, Gunertem OE, McCusker K, Kunt AT, Onur MA, et al. Comparative Effects of Single-Dose Cardioplegic Solutions Especially in Repeated Doses During Minimally Invasive Aortic Valve Surgery. Innovations (Philadelphia, Pa.). 2021; 16: 80–89.
Ishihama S, Yoshida S, Yoshida T, Mori Y, Ouchi N, Eguchi S, et al. LPL/AQP7/GPD2 promotes glycerol metabolism under hypoxia and prevents cardiac dysfunction during ischemia. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 2021; 35: e22048.
